Tharakan Tharu, Miah Saiful, Jayasena Channa, Minhas Suks
Department of Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
Section of Investigative Medicine, Department of Medicine, Imperial College London, London, UK.
F1000Res. 2019 Mar 25;8. doi: 10.12688/f1000research.16561.1. eCollection 2019.
Late-onset hypogonadism (LOH) is the term used to describe the decline in serum testosterone levels associated with increasing age in men above 40 years. A number of symptoms are attributed to LOH, but the most common association is that of sexual dysfunction. LOH has recently come under greater scrutiny with the widespread use of testosterone therapy, and concerns regarding the efficacy and safety of testosterone replacement therapy have been raised. In particular, the cardiovascular safety and the beneficial effects of testosterone replacement therapy on general health have been questioned. This review will give an overview of the current evidence for the relationship of LOH and male sexual dysfunction.
迟发性性腺功能减退(LOH)是用于描述40岁以上男性血清睾酮水平随年龄增长而下降的术语。许多症状都归因于LOH,但最常见的关联是性功能障碍。随着睾酮疗法的广泛应用,LOH最近受到了更多的审视,并且人们对睾酮替代疗法的疗效和安全性提出了担忧。特别是,睾酮替代疗法的心血管安全性及其对总体健康的有益作用受到了质疑。本综述将概述目前关于LOH与男性性功能障碍关系的证据。